Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01866514 · ClinicalTrials.gov registry record · NA

Proximal Humerus Site for Anesthesia

A NA study of Intraosseous Vascular Access, sponsored by Vidacare Corporation.

Completed
Registry status
NA
Development phase
5
Enrollment target
1
Study location

NCT01866514: Completed NA study of Intraosseous Vascular Access, sponsored by Vidacare Corporation.

NCT01866514 is a NA study of Intraosseous Vascular Access that has completed, run by Vidacare Corporation. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01866514, a NA study of Intraosseous Vascular Access, has completed, sponsored by Vidacare Corporation.

COMPLETED
Registry status
NA
Development phase
5 participants
Enrollment target
1
Study location

Study Summary

This will be a prospective, non-controlled study using healthy adult volunteers as subjects receiving bilateral proximal humerus intraosseous (IO) vascular access to evaluate the insertion technique and IO infusion flow rates.

Primary Outcome

the mean infusion flow rate reported in milliliters per hour (mL/hr) obtained at each tested infusion pressure.

Interventions

  • PROCEDURE proximal humerus intraosseous vascular access
  • DRUG 2% preservative-free lidocaine
  • DEVICE EZ-IO

Study Locations (1)

Texas

  • Bulverde-Spring Branch EMS - Spring Branch

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2013-05
Est. Completion 2013-06
Phase NA
Vidacare Corporation

11 total trials

What the finished NCT01866514 record still lists

NCT01866514 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Intraosseous Vascular Access appearing as the primary indexed condition, and to 3 interventions - of which proximal humerus intraosseous vascular access is the first listed.

NCT01866514 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT01866514 about?

NCT01866514 is a clinical study titled "Proximal Humerus Site for Anesthesia". This will be a prospective, non-controlled study using healthy adult volunteers as subjects receiving bilateral proximal humerus intraosseous (IO) vascular access to evaluate the insertion technique and IO infusion flow rates.

What is the current status of trial NCT01866514?

This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2013-05. Estimated completion is 2013-06.

What conditions does trial NCT01866514 study?

This clinical trial studies the following conditions: Intraosseous Vascular Access.

What interventions are being tested in trial NCT01866514?

The interventions under investigation include: proximal humerus intraosseous vascular access (PROCEDURE), 2% preservative-free lidocaine (DRUG), EZ-IO (DEVICE).

Who is sponsoring clinical trial NCT01866514?

This trial is sponsored by Vidacare Corporation, which has 11 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01866514 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Intraosseous Vascular Access

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01866514's enrollment target sits among peer trials

5 1988th of 2000 higher than 5 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01866514, the US trial registry maintained by the National Library of Medicine. NCT01866514 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.